Following adjustment for age, BMI, FIGO stage, disease grade, histology, LVSI, depth of myometrial invasion and baseline CRP, those with T2DM had a two-fold increase in the risk of disease recurrence compared to those without (adjusted HR 2.22, 95% CI 1.08-4.56, p=0.030). The gene discussed is CRP; the disease is type 2 diabetes mellitus.